药物受理最新动态：Merck Sharp & Dohme LLC九价人乳头瘤病毒疫苗(酿酒酵母...

Core Viewpoint - The application for the nine-valent human papillomavirus vaccine (yeast) by Merck Sharp & Dohme LLC has been accepted by the National Medical Products Administration, indicating a significant step in the vaccine's regulatory process [1] Group 1: Application Details - The application acceptance date is December 24, 2025, with the acceptance number JYSB2500306 [1] - The vaccine is classified as a preventive biological product and is categorized under supplementary application registration [1] - The companies involved include Merck Sharp & Dohme LLC and MSD Ireland (Carlow) [1]